Viewing nowLyrica CR Extended-Release Tablets 165 mg (Pregabalin)
Pregabalin 165mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

MFDS item code 201802990 · Approved 2018.07.18 · Insurance code 073400260
Treatment of peripheral neuropathic pain in adults
This medication is used to treat pain caused by peripheral neuropathy in adults.
This medicine is administered once daily after the evening meal. An initial dose of 165 mg once daily may be administered. Based on the response and tolerability of the individual patient, the dose may be increased to 330 mg once daily after 3 to 7 days. If necessary, the dose may subsequently be increased at 7-day intervals to a maximum of 660 mg daily. When switching from Lyrica Capsules to Lyrica CR Extended-Release Tablets, take the morning dose of Lyrica Capsules as prescribed on the day of the switch, and begin taking Lyrica CR Extended-Release Tablets after the evening meal. 75 mg/day → 82.5 mg/day 150 mg/day → 165 mg/day 225 mg/day → 247.5 mga/day 300 mg/day → 330 mg/day 450 mg/day → 495 mgb/day 600 mg/day → 660 mgc/day a. 247.5 mg= 3×82.5 mg tablets administered once daily b. 495 mg= 3×165 mg tablets administered once daily c. 660 mg=2×330 mg tablets administered once daily If treatment with this medicine is discontinued, it should be withdrawn gradually over at least 1 week. Use of this medicine is not recommended in patients with creatinine clearance below 30 mL/min or in patients undergoing hemodialysis. These patients should receive Lyrica Capsules. ≥60 mL/min: 165 mg, 330 mg, 495a mg, 660b mg; once daily 30-60 mL/min: 82.5 mg, 165 mg, 247.5c mg, 330 mg; once daily <30 or hemodialysis: administer Lyrica Capsules a. 495 mg= 3×165 mg tablets administered once daily b. 660 mg= 2×330 mg tablets administered once daily c. 247.5 mg=3×82.5 mg tablets administered once daily Dose adjustment is not required in patients with hepatic impairment. 65 years of age and older: Dose reduction may be necessary in older adults with impaired renal function.
Children under 12 years of age: Use is not recommended because there are insufficient safety and efficacy data. Adolescents aged 12-17 years: Use is not recommended because there are insufficient safety and efficacy data.
This medication may increase the risk of suicidal thoughts or behaviors, so careful monitoring for depression, mood changes, or abnormal behavior is required during treatment. Do not use if allergic to any components of this medication. Diabetic patients may have difficulty controlling blood sugar due to weight gain, which may require adjustments in blood sugar medication dosages. If serious allergic reactions such as angioedema occur, stop taking the medication immediately and inform your healthcare provider. Elderly patients may experience dizziness, drowsiness, or confusion, so special caution is needed when starting this medication. Visual disturbances such as blurred vision may occur, and if symptoms persist, consult a physician. Suddenly stopping this medication may lead to withdrawal symptoms such as insomnia, headache, and anxiety; therefore, it should be gradually reduced following a doctor's instructions. Patients with a history of mental illness or substance abuse may be at risk for drug dependence, so caution is advised. Patients with impaired kidney function should have their dosages of this medication adjusted, and it is not recommended for patients on dialysis. Patients with heart conditions should be cautious, as cardiovascular problems such as congestive heart failure may occur while taking this medication. There is a risk of respiratory depression if taken in combination with central nervous system depressants or opioid analgesics; caution is needed when taken together. During early pregnancy, there is a risk of fetal malformation; therefore, it is advisable for pregnant women not to take this medication and for women of childbearing age to use effective contraception methods. This medication may be excreted in breast milk, so consider stopping breastfeeding or discontinuing the medication while nursing. Dizziness or drowsiness may occur while taking this medication, so it is safe to avoid driving or operating hazardous machinery. Severe skin reactions may rarely occur, so if symptoms such as rash, blisters, or mucosal damage appear, discontinue use immediately and consult your healthcare provider. Overdose may cause confusion, drowsiness, seizures, etc., and appropriate treatment such as dialysis should be received if necessary. This medication should be kept out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is also important to store it at room temperature, between 1 degree and 30 degrees Celsius, avoiding temperatures that are too hot or too cold.
Pale orange almond-shaped film-coated extended-release tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 165mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.